fulvestrant has been researched along with indocyanine green in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fink, T; Hinkelbein, J; Mathes, A; Mertke, T; Volk, T; Wolf, A | 1 |
1 review(s) available for fulvestrant and indocyanine green
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for fulvestrant and indocyanine green
| Article | Year |
|---|---|
Resveratrol therapy improves liver function via estrogen-receptors after hemorrhagic shock in rats.
Topics: Animals; Cytokines; Estrogen Receptor Antagonists; Estrogens; Fulvestrant; Hemorrhage; Indocyanine Green; Liver; Male; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Resuscitation; Resveratrol; Ringer's Solution; Shock, Hemorrhagic | 2022 |